# A Study to Assess Disability in Anemic Elderly Patients With Kidney Disease Receiving PROCRIT (Epoetin Alfa)

> **NCT00338468** · PHASE4 · TERMINATED · sponsor: **Ortho Biotech Products, L.P.** · enrollment: 13 (actual)

## Conditions studied

- Anemia
- Kidney Diseases

## Interventions

- **DRUG:** epoetin alfa

## Key facts

- **NCT ID:** NCT00338468
- **Lead sponsor:** Ortho Biotech Products, L.P.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-11
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** The study was stopped early due to slow enrollment.
- **Last updated:** 2011-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00338468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00338468, "A Study to Assess Disability in Anemic Elderly Patients With Kidney Disease Receiving PROCRIT (Epoetin Alfa)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00338468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*